SCHEMBL26880958

SCHEMBL26880958

Cc1c2c(c3c(c1C(C)(C)C)CCC3)OC(C)(C(C)(C)C)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20932923 0.57 — —
SCHEMBL22899740 0.57 — —
SCHEMBL20933006 0.57 — —
SCHEMBL22905636 0.57 — —
SCHEMBL12733214 0.56 — —
SCHEMBL25067008 0.56 — —
SCHEMBL24977996 0.53 KDM4E (0.34) —
SCHEMBL24977966 0.53 SMN1; SMN2 (0.42) —
SCHEMBL20933020 0.53 ALDH1A1 (0.39) —
SCHEMBL22899727 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365541-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-11-16 — — US disclosed
US-20230365541-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-11-16 — — US disclosed
Send feedback